The potential dichotomy in PMCA2 levels between subtypes and its correlation with survival in the basal subtype is exemplified by the very different association between EGFR and PMCA2 in all breast cancers (positive correlation) versus the basal subtype (negative correlation). This evidence concerns the gene ATP2B2 and breast carcinoma.